| ²é¿´: 722 | »Ø¸´: 9 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
[½»Á÷]
¡¾ÇóÖú¡¿¹ØÓÚFDA²éÕÒÒ©ÎïÎÊÌâ
|
|||
|
ÇëÎʸ÷룬ÈçºÎͨ¹ý¾ßÌåµÄ¼ÁÐÍÔÚFDAÉϲéѯÒÑÉÏÊеÄÒ©ÎïÄØ£¿±ÈÈç˵²éѯÒÑÉÏÊеÄÖ¬ÖÊÌå¡¢»ò΢Çò¡¢Èé¼ÁÖ®ÀàµÄÒ©ÎïÓÐÄÄЩ£¿ ÏÈллÁË~~~ |
» ²ÂÄãϲ»¶
publcifµÄʹÓÃ
ÒѾÓÐ0È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ2È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ166È˻ظ´
»á¼Æ×¨Ë¶Çóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ÐÂ¼ÓÆÂ¹úÁ¢´óѧҩѧϵ»¯Ñ§ÉúÎïѧ¿ÎÌâ×éÕÐPhD
ÒѾÓÐ14È˻ظ´
Çë½Ìõ£°·ËõºÏ·´Ó¦
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸´óÁ¬Àí¹¤ÖÆÒ©¹¤³Ìר˶086002£¬±¾¿Æ211£¬×Ü·Ö342
ÒѾÓÐ0È˻ظ´
ÖÆÒ©¹¤³ÌרҵÕÐÊÕµ÷¼Á£¬ÒªÇó¹ý¹ú¼ÒÏß
ÒѾÓÐ0È˻ظ´
ÎåÒØ´óѧҩÎﻯѧÉúÎïѧÍŶÓ-ÀîÀ¼Çå¿ÎÌâ×éÕÐÊÕµ÷¼ÁѧÉú
ÒѾÓÐ0È˻ظ´
sara_na
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 720.1
- Ìû×Ó: 153
- ÔÚÏß: 24.7Сʱ
- ³æºÅ: 630517
- ×¢²á: 2008-10-19
- ÐÔ±ð: MM
- רҵ: Ò©Îï·ÖÎö
8Â¥2009-09-09 13:57:28
ÏôС
ľ³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3948.5
- Ìû×Ó: 9
- ÔÚÏß: 149.8Сʱ
- ³æºÅ: 230985
- ×¢²á: 2006-03-26
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ

2Â¥2009-09-02 14:28:41
¾ê×Ó
ͳæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 134.2
- ºì»¨: 1
- Ìû×Ó: 57
- ÔÚÏß: 21.2Сʱ
- ³æºÅ: 204662
- ×¢²á: 2006-03-02
- רҵ: Ò©¼Áѧ
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
|
Orange Book (Approved Drug Products with Therapeutic Equivalence Evaluations) about the database http://www.fda.gov/Drugs/InformationOnDrugs/default.htm |

4Â¥2009-09-03 09:53:14
abitcom
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 663.2
- É¢½ð: 1
- Ìû×Ó: 289
- ÔÚÏß: 159.1Сʱ
- ³æºÅ: 45020
- ×¢²á: 2004-05-08
- ÐÔ±ð: GG
- רҵ: Ò©Îï×ÊÔ´

5Â¥2009-09-08 14:22:20














»Ø¸´´ËÂ¥